Tauopathy with paired helical filaments in an aged chimpanzee

Journal of Comparative Neurology

Volumn 509, Issue 3, 2008, Pages 259-270

  Rosen, Rebecca F ^a   Farberg, Aaron S ^a   Gearing, Marla ^b   Dooyema, Jeromy ^a   Long, Patrick M ^a   Anderson, Daniel C ^a   Davis Turak, Jeremy ^c   Coppola, Giovanni ^c   Geschwind, Daniel H ^c   Paré, Jean Francois ^a   Duong, Timothy Q ^a,b   Hopkins, William D ^a   Preuss, Todd M ^a,b   Walker, Lary C ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

A ; Aging; Alzheimer's disease; Amyloid; Cerebral amyloid angiopathy; Neurodegeneration; Neurofibrillary tangles; Pan troglodytes; Proteopathy; Senile plaques; Tau

Indexed keywords

TAU PROTEIN; AMYLOID BETA PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL AGGREGATION; CELL DEATH; CHIMPANZEE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HISTOPATHOLOGY; IMMUNOREACTIVITY; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPIL THREAD; NONHUMAN; PAIRED HELICAL FILAMENT; PAN TROGLODYTES; PATHOGENESIS; PLAQUE FORMING CELL; PRIORITY JOURNAL; TAUOPATHY; VASCULARIZATION; ANIMAL; ANIMAL DISEASE; BRAIN; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOLOGY; SENILE PLAQUE; STROKE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROFIBRILLARY TANGLES; NEUROPIL THREADS; PAN TROGLODYTES; SENILE PLAQUES; STROKE; TAU PROTEINS; TAUOPATHIES;

EID: 47049120305     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21744     Document Type: Article

References (74)

1. Arriagada PV, Marzloff K, Hyman BT. 1992. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42:1681-1688.
2. Bailey P, von Bonin G, McCulloch W. 1950. The isocortex of the chimpanzee. Urbana, IL: University of Illinois Press.
3. Ballatore C, Lee VM, Trojanowski JQ. 2007. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8:663-672.
4. Bloom GS, Ren K, Glabe CG. 2005. Cultured cell and transgenic mouse models for tau pathology linked to beta-amyloid. Biochim Biophys Acta 1739:116-124.
5. Borkowski R, Taylor TG, Rush J. 2000. Cerebral infarction and myocardial fibrosis in a white-handed gibbon (Hylobates lar). J Zoo Wild Med 31:65-70.
6. Braak H, Braak E. 1994. Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 15:355-356.
7. Brodmann K. 1909. Vergleichende Lokalisationslehre der Grosshirnrhinde. Leipzig: Barth.
8. Catalano SM, Dodson EC, Henze DA, Joyce JG, Krafft GA, Kinney GG. 2006. The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. Curr Top Med Chem 6:597-608.
9. Conrad C, Vianna C, Schultz C, Thal DR, Ghebremedhin E, Lenz J, Braak H, Davies P. 2004. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease. J Neurochem 89:179-188.
10. Cork LC, Walker LC. 1993. Age-related lesions, nervous system. In: Jones TC, Mohr U, Hunt RD, editors. Monographs on pathology of laboratory animals: nonhuman primates II. Berlin: Springer-Verlag. p 173-183.
11. Cork LC, Powers RE, Selkoe DJ, Davies P, Geyer JJ, Price DL. 1988. Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 47:629-641.
12. Crowther RA. 1991. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci U S A 88:2288-2292.
13. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L. 1988. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38:1682-1687.
14. Duyckaerts C, Colle MA, Dessi F, Piette F, Hauw JJ. 1998. Progression of Alzheimer histopathological changes. Acta Neurol Belg 98:180-185.
15. Elfenbein HA, Rosen RF, Stephens SL, Switzer RC, Smith Y, Pare J, Mehta PD, Warzok R, Walker LC. 2007. Cerebral beta-amyloid angiopathy in aged squirrel monkeys. Histol Histopathol 22:155-167.
16. Erwin JM, Nimchinsky EA, Gannon PJ, Perl DP, Hof PR. 2000. The study of brain aging in great apes. In: Hof PR, Mobbs CV, editors. Functional neurobiology of aging: New York: Academic Press. p 447-456.
17. Ewing B, Green P. 1998. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8:186-194.
18. Ewing B, Hillier L, Wendl MC, Green P. 1998. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8:175-185.
19. Fish PH, Carpenter JW, Kraft S. 2004. Diagnosis and treatment of a cerebral infarct in a chimpanzee (Pan troglodytes). J Zoo Wild Med 35:203-207.
20. Gearing M, Rebeck GW, Hyman BT, Tigges J, Mirra SS. 1994. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci U S A 91:9382-9386.
21. Gearing M, Tigges J, Mori H, Mirra SS. 1996. Abeta40 is a major form of beta-amyloid in nonhuman primates. Neurobiol Aging 17:903-908.
22. Gearing M, Tigges J, Mori H, Mirra SS. 1997. Beta-amyloid (Abeta) deposition in the brains of aged orangutans. Neurobiol Aging 18:139-146.
23. Geula C, Nagykery N, Wu CK. 2002. Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. Acta Neuropathol 103:48-58.
24. Giannakopoulos P, Gold G, Kovari E, von Gunten A, Imhof A, Bouras C, Hof PR. 2007. Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol 113:1-12.
25. Goedert M. 2004. Tau protein and neurodegeneration. Semin Cell Dev Biol 15:45-49.
26. Goedert M, Jakes R. 2005. Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta 1739:240-250.
27. Goedert M, Jakes R, Vanmechelen E. 1995. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189:167-169.
28. Gotz J, Chen F, van Dorpe J, Nitsch RM. 2001. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491-1495.
29. Greenberg SG, Davies P, Schein JD, Binder LI. 1992. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564-569.
30. Hardy J, Orr H. 2006. The genetics of neurodegenerative diseases. J Neurochem 97:1690-1699.
31. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
32. Hardy J, Pittman A, Myers A, Fung HC, de Silva R, Duckworth J. 2006. Tangle diseases and the tau haplotypes. Alzheimer Dis Assoc Disord 20:60-62.
33. Hartig W, Bruckner G, Schmidt C, Brauer K, Bodewitz G, Turner JD, Bigl V. 1997. Co-localization of beta-amyloid peptides, apolipoprotein E and glial markers in senile plaques in the prefrontal cortex of old rhesus monkeys. Brain Res 751:315-322.
34. Hartig W, Klein C, Brauer K, Schüppel KF, Arendt T, Brückner G, Bigl V. 2000. Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders. Acta Neuropathol 100:305-12.
35. Herndon JG, Tigges J, Anderson DC, Klumpp SA, McClure HM. 1999. Brain weight throughout the life span of the chimpanzee. J Comp Neurol 409:567-572.
36. Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K. 2001. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 297:187-190.
37. Holzer M, Craxton M, Jakes R, Arendt T, Goedert M. 2004. Tau gene (MAPT) sequence variation among primates. Gene 341:313-322.
38. Imai Y, Ibata I, Ito D, Oshawa K, Kohsaka S. 1996. A novel gene Iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocyte lineage. Biochem Biophys Res Commun 224:855-862.
39. Jicha GA, Bowser R, Kazam IG, Davies P. 1997. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128-132.
40. Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, Davies P. 1999. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J Neurosci 19:7486-7494.
41. Kalaria RN. 2000. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21:321-330.
42. Kawas C, Katzman R. 1999. Epidemiology of dementia and Alzheimer disease. In: Terry RD, Katzman R, Bick KL, Sisodia SS, editors. Alzheimer disease, 2nd ed. Philadelphia: Lippincott Williams & Wilkins. p 95-116.
43. Kiatipattanasakul W, Nakayama H, Yongsiri S, Chotiapisitkul S, Nakamura S, Kojima H, Doi K. 2000. Abnormal neuronal and glial argyrophilic fibrillary structures in the brain of an aged albino cynomolgus monkey (Macaca fascicularis). Acta Neuropathol 100:580-586.
44. Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, Dickson DW, Golde T, McGowan E. 2007. Abeta40 inhibits amyloid deposition in vivo. J Neurosci 27:627-633.
45. Kim KS, Miller DL, Sapienza VJ, Chen CMJ, Bai C, Grundke-Iqbal I, Currie JR, Wisniewski HM. 1988. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 2:121-130.
46. Kimura N, Tanemura K, Nakamura S, Takashima A, Ono F, Sakakibara I, Ishii Y, Kyuwa S, Yoshikawa Y. 2003. Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem Biophys Res Commun 310:303-311.
47. Komori T, Arai N, Oda M, Nakayama H, Mori H, Yagishita S, Takahashi T, Amano N, Murayama S, Murakami S, Shibata N, Kobayashi M, Sasaki S, Iwata M. 1998. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 96:401-408.
48. Lee VM-Y, Goedert M, Trojanowski JQ. 2001. Neurodegenerative Tauopathies. Annu Rev Neurosci 24:1121-1159.
49. Mandelkow E, von Bergen M, Biernat J, Mandelkow EM. 2007. Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain Pathol 17:83-90.
50. McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Golde T. 2005. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47:191-199.
51. Mestre-Frances N, Keller E, Calenda A, Barelli H, Checler F, Bons N. 2000. Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles. Neurobiol Dis 7:1-8.
52. Metuzals J. 1986. Neurofilaments and paired helical filaments. In: Metuzals J, editor. Electron microscopy and Alzheimer's disease. San Francisco: San Francisco Press, Inc. p 34-37.
53. Nakamura S, Kiatipattanasakul W, Nakayama H, Ono F, Sakakibara I, Yoshikawa Y, Goto N, Doi K. 1996. Immunohistochemical characteristics of the constituents of senile plaques and amyloid angiopathy in aged cynomolgus monkeys. J Med Primatol 25:294-300.
54. Nakamura S, Tamaoka A, Sawamura N, Kiatipattanasakul W, Nakayama H, Shoji S, Yoshikawa Y, Doi K. 1997. Deposition of amyloid beta protein (Abeta) subtypes [A beta 40 and A beta 42(43)] in canine senile plaques and cerebral amyloid angiopathy. Acta Neuropathol 94:323-328.
55. Nelson PT, Saper CB. 1995. Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep. Neurobiol Aging 16:315-323.
56. Nelson PT, Marton L, Saper CB. 1993. Alz-50 immunohistochemistry in the normal sheep striatum: a light and electron microscope study. Brain Res 600:285-297.
57. Nelson PT, Greenberg SG, Saper CB. 1994. Neurofibrillary tangles in the cerebral cortex of sheep. Neurosci Lett 170:187-190.
58. Nelson PT, Stefansson K, Gulcher J, Saper CB. 1996. Molecular evolution of tau protein: implications for Alzheimer's disease. J Neurochem 67: 1622-1632.
59. Ohm TG, Meske V. 2006. Cholesterol, statins and tau. Acta Neurol Scand Suppl 185:93-101.
60. Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM. 1994. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669-673.
61. Piccardo P, Mirra SS, Young K, Gearing M, Dlouhy SR, Ghetti B. 1998. α-Synuclein accumulation in Gerstmann-Straussler-Schenker disease (GSS) with prion protein gene (PRNP) F198S. Neurobiol Aging 19:S724.
62. Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, Marlowe L, Duckworth J, Leung D, Williams D, Kilford L, Thomas N, Morris CM, Dickson D, Wood NW, Hardy J, Lees AJ, de Silva R. 2005. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet 42:837-846.
63. Poduri A, Gearing M, Rebeck GW, Mirra SS, Tigges J, Hyman BT. 1994. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Am J Pathol 144:1183-1187.
64. Popa-Wagner A, Schroder E, Walker LC, Kessler C. 1998. Beta-amyloid precursor protein and beta-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: effect of age. Stroke 29:2196-2202.
65. Potempska A, Mack K, Mehta P, Kim KS, Miller DL. 1999. Quantification of sub-femtomole amounts of Alzheimer amyloid beta peptides. Amyloid 6:14-21.
66. Raby CA, Morganti-Kossmann MC, Kossmann T, Stahel PF, Watson MD, Evans LM, Mehta PD, Spiegel K, Kuo YM, Roher AE, Emmerling MR. 1998. Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. J Neurochem 71:2505-2509.
67. Roertgen KE, Parisi JE, Clark HB, Barnes DL, O'Brien TD, Johnson KH. 1996. Abeta-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine ( Gulo gulo). Neurobiol Aging 17:243-247.
68. Schultz C, Hubbard GB, Tredici KD, Braak E, Braak H. 2001. Tau pathology in neurons and glial cells of aged baboons. Adv Exp Med Biol 487:59-69.
69. Walker LC, Cork LC. 1999. The neurobiology of aging in nonhuman primates. In: Terry RD, Katzman R, Bick KL, Sisodia SS, editors. Alzheimer disease, 2nd ed. Philadelphia: Lippincott Williams & Wilkins. p 233-243.
70. Walker LC, Masters C, Beyreuther K, Price DL. 1990. Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol 80:381-387.
71. Walsh DM, Selkoe DJ. 2007. Abeta oligomers - a decade of discovery. J Neurochem 101:1172-1184.
72. Wen Y, Yang SH, Liu R, Perez EJ, Brun-Zinkernagel AM, Koulen P, Simpkins JW. 2007. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 1772:473-483.
73. Wilcock GK, Esiri MM. 1982. Plaques, tangles and dementia. A quantitative study. J Neurol Sci 56:343-356.
74. Williams DR. 2006. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J 36:652-660.